P-selectin has been demonstrated to bind to a variety of human cancers and cancer-derived cell lines in vitro, including colon cancer, small cell lung cancer, breast cancer, melanoma, neuroblastoma and adenoid cancer, where P-selectin has been shown to contribute to tumour cell extravasation (68–73). Here, SELP is linked to breast carcinoma.